NO981394D0 - Faste legemiddelformer som kan oppnås ved ekstrudering av en isomaltholdig polymersmelte som inneholder virkestoff - Google Patents

Faste legemiddelformer som kan oppnås ved ekstrudering av en isomaltholdig polymersmelte som inneholder virkestoff

Info

Publication number
NO981394D0
NO981394D0 NO981394A NO981394A NO981394D0 NO 981394 D0 NO981394 D0 NO 981394D0 NO 981394 A NO981394 A NO 981394A NO 981394 A NO981394 A NO 981394A NO 981394 D0 NO981394 D0 NO 981394D0
Authority
NO
Norway
Prior art keywords
isomalt
extruding
active ingredient
polymer melt
solid pharmaceutical
Prior art date
Application number
NO981394A
Other languages
English (en)
Other versions
NO981394L (no
Inventor
Juergen Zeidler
Joerg Rosenberg
Joerg Neumann
Joerg Breitenbach
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO981394L publication Critical patent/NO981394L/no
Publication of NO981394D0 publication Critical patent/NO981394D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Indole Compounds (AREA)
NO981394A 1995-09-29 1998-03-27 Faste legemiddelformer som kan oppnås ved ekstrudering av en isomaltholdig polymersmelte som inneholder virkestoff NO981394D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19536394A DE19536394A1 (de) 1995-09-29 1995-09-29 Feste Arzneiformen, erhältlich durch Extrusion einer Isomalt enthaltenden Polymer-Wirkstoff-Schmelze
PCT/EP1996/004262 WO1997012603A1 (de) 1995-09-29 1996-09-30 Feste arzneiformen, erhältlich durch extrusion einer isomalt enthaltenden polymer-wirkstoff-schmelze

Publications (2)

Publication Number Publication Date
NO981394L NO981394L (no) 1998-03-27
NO981394D0 true NO981394D0 (no) 1998-03-27

Family

ID=7773633

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981394A NO981394D0 (no) 1995-09-29 1998-03-27 Faste legemiddelformer som kan oppnås ved ekstrudering av en isomaltholdig polymersmelte som inneholder virkestoff

Country Status (22)

Country Link
US (1) US6187342B1 (no)
EP (1) EP0854707B1 (no)
JP (1) JP4041163B2 (no)
KR (1) KR19990063853A (no)
CN (1) CN1200694C (no)
AT (1) ATE228355T1 (no)
AU (1) AU7282896A (no)
BG (1) BG102346A (no)
BR (1) BR9610799A (no)
CA (1) CA2230950C (no)
CZ (1) CZ95998A3 (no)
DE (2) DE19536394A1 (no)
DK (1) DK0854707T3 (no)
ES (1) ES2187678T3 (no)
HU (1) HUP9903384A3 (no)
IL (1) IL123250A (no)
MX (1) MX9801988A (no)
NO (1) NO981394D0 (no)
RU (1) RU2197228C2 (no)
TW (1) TW438599B (no)
WO (1) WO1997012603A1 (no)
ZA (1) ZA968130B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19809242A1 (de) * 1998-03-05 1999-09-09 Basf Ag Verfahren zur Herstellung von festen, sphärischen Formkörpern, enthaltend pharmazeutische Wirkstoffe in einer Bindemittelmatrix
US6465009B1 (en) 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
WO2001034119A2 (en) * 1999-11-12 2001-05-17 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
US20070141107A1 (en) * 2000-03-15 2007-06-21 Orbusneich Medical, Inc. Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
US8088060B2 (en) * 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
KR20040100835A (ko) * 2001-02-15 2004-12-02 킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 안정된 제약및 갑상선 내분비 호르몬 구성물 및 그제조방법
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
PL364621A1 (en) * 2001-03-26 2004-12-13 Smithkline Beecham Corporation Nicotine-containing oral dosage form
FR2823974B1 (fr) * 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
US20030198667A1 (en) * 2001-08-10 2003-10-23 Franz Andrew G. Methods of producing dispersible pharmaceutical compositions
US20030180353A1 (en) * 2001-08-10 2003-09-25 Franz G. Andrew Stabilized pharmaceutical compositions
US20030190349A1 (en) * 2001-08-10 2003-10-09 Franz G. Andrew Methods of stabilizing pharmaceutical compositions
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20030203967A1 (en) * 2001-08-14 2003-10-30 Franz G. Andrew Levothyroxine compositions having unique Tmax properties
US20030195253A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US20030198672A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030199587A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique Cmax properties
US20030199586A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Unique levothyroxine aqueous materials
US20030175337A1 (en) * 2001-10-29 2003-09-18 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
KR100514590B1 (ko) * 2001-12-18 2005-09-14 주식회사 대웅 프라바스타틴나트륨 및 안정화제로서의 코폴리비돈을함유하는 약제 조성물
US20040101543A1 (en) * 2002-03-22 2004-05-27 John Liu Nicotine-containing oral dosage form
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
DE60313359T2 (de) * 2002-12-17 2008-01-03 Abbott Gmbh & Co. Kg Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
WO2004069138A2 (en) * 2003-02-03 2004-08-19 Novartis Ag Pharmaceutical formulation
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
GB2418854B (en) * 2004-08-31 2009-12-23 Euro Celtique Sa Multiparticulates
EP2140861A1 (en) * 2008-06-30 2010-01-06 Abbott GmbH & Co. KG Pharmaceutical dosage form comprising polymeric carrier composition
BR112013008737A2 (pt) * 2010-10-14 2015-09-01 Abbott Gmbh & Co Kg Formulação de dispersão sólida de curcuminóide
JP5954676B2 (ja) 2011-03-21 2016-07-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アンブロキソールを含む固体製剤
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
WO2017175792A1 (ja) * 2016-04-06 2017-10-12 アステラス製薬株式会社 速溶出性三次元造形物、速溶出性三次元造形物用フィラメント及び速溶出性三次元造形物用材料

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612211A1 (de) 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
DE3826946C1 (no) 1988-08-09 1990-03-15 A. Nattermann & Cie Gmbh, 5000 Koeln, De
ATE221772T1 (de) 1994-06-14 2002-08-15 Biovail Tech Ltd Verfahren und apparat zur herstellung von schnelllöslichen dosierungseinheiten und daraus erhältliches produkt

Also Published As

Publication number Publication date
JPH11512729A (ja) 1999-11-02
DK0854707T3 (da) 2002-12-16
EP0854707B1 (de) 2002-11-27
NO981394L (no) 1998-03-27
EP0854707A1 (de) 1998-07-29
IL123250A0 (en) 1998-09-24
RU2197228C2 (ru) 2003-01-27
TW438599B (en) 2001-06-07
IL123250A (en) 2000-08-31
ATE228355T1 (de) 2002-12-15
BG102346A (bg) 1998-10-30
CN1198094A (zh) 1998-11-04
DE19536394A1 (de) 1997-04-03
CN1200694C (zh) 2005-05-11
CA2230950A1 (en) 1997-04-10
ES2187678T3 (es) 2003-06-16
AU7282896A (en) 1997-04-28
JP4041163B2 (ja) 2008-01-30
KR19990063853A (ko) 1999-07-26
BR9610799A (pt) 1999-07-13
HUP9903384A3 (en) 2001-04-28
CA2230950C (en) 2007-12-04
MX9801988A (es) 1998-08-30
US6187342B1 (en) 2001-02-13
CZ95998A3 (cs) 1998-08-12
ZA968130B (en) 1998-03-27
WO1997012603A1 (de) 1997-04-10
DE59609923D1 (de) 2003-01-09
HUP9903384A2 (hu) 2000-10-28

Similar Documents

Publication Publication Date Title
NO981394D0 (no) Faste legemiddelformer som kan oppnås ved ekstrudering av en isomaltholdig polymersmelte som inneholder virkestoff
NO973730L (no) Faste virkestofftilberedninger
HUP0104573A2 (hu) Agrokémiai készítmények
CA2290017A1 (en) Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance
CA2356380A1 (en) Immunosuppressive effects of pteridine derivatives
EP1138321A3 (de) Feste orale Darreichungsformen mit retardierter Wirkstoffreisetzung und hoher mechanischer Stabilität
BR0103033A (pt) Partìculas farmacêuticas de sabor mascarado
HUP9801151A2 (hu) Stabilan tárolható gyógyszerformák
WO1997012583A3 (en) Stable compositions containing n-propargyl-1-aminoindan
WO2006035417A3 (en) Dihydropyrimidine microcapsule - formulations
EP1158021A4 (en) MICROGELS AND EXTERNAL APPLICATION PREPARATIONS CONTAINING THESE MICROGELS
BR9611802A (pt) Composições farmacêuticas
NO20062051L (no) Farmasoytisk virkestoffinneholdende formulering med belegg
CA2385890A1 (en) Controlled release compositions comprising nimesulide
BRPI0417043A (pt) composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição
CA2294783A1 (fr) Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine
CA2343732A1 (en) Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto
CA2227272A1 (en) Use of lipids as aids in the production of solid drug forms by melt extrusion
CA2136331A1 (en) New pharmaceutical uses of krill enzymes
WO2005065639A3 (en) Novel pharmaceutical compositions
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
AU3885099A (en) Cosmetic compositions
AP1595A (en) Pharmaceutical formulation having a masked taste and method for the production thereof.
AU7599900A (en) Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles
WO2000064427A3 (en) Lamivudine containing pharmaceutical formulation